Voranidini (Voranigo) is a targeted therapeutic drug for IDH1/2-mutant lower-grade gliomas, with the brand name VORANIGO®. As a prescription medication, its purchase and use must strictly comply with medical regulations.
How to Purchase Voranidini (Voranigo)
Overseas Purchase
Patients may choose to consult and purchase Voranidini (Voranigo) at hospital pharmacies or authorized drugstores in countries or regions where the drug has been launched.
Since drug prices may be affected by factors such as regional differences and exchange rate fluctuations, patients need to make a budget and plan in advance before purchasing.
Purchase through Medical Service Institutions
Patients can consult domestic overseas medical service institutions that cooperate with international pharmacies or pharmaceutical companies.
These institutions usually provide legal import channels and offer professional consultation and guidance.
Precautions for Purchasing Voranidini (Voranigo)
Prescription and Medical Supervision
Voranidini must be used strictly under the guidance of a doctor.
Patients have confirmed the presence of IDH1 or IDH2 mutations through genetic testing.
The tumor is pathologically graded as grade 2 astrocytoma or oligodendroglioma.
Patients have completed surgical treatment (including biopsy, subtotal resection, or total resection).
Dosage Selection
10mg: White round film-coated tablets, with "10" printed on one side.
40mg: White oval film-coated tablets, with "40" printed on one side.
The standard adult dosage is 40mg once daily. For pediatric patients aged 12 years and above, the dosage is adjusted based on body weight (≥40kg: 40mg/day; <40kg: 20mg/day). When purchasing, patients must confirm that the drug specification is consistent with the doctor's advice.
Storage Conditions
Voranidini should be stored at 20°C to 25°C (68°F to 77°F), with short-term storage allowed within the range of 15°C to 30°C (59°F to 86°F).
The medicine bottle contains a desiccant; do not remove or ingest the desiccant.
Methods to Identify the Authenticity of Voranidini (Voranigo)
Packaging Features
The bottle is made of white opaque plastic.
The bottle cap is designed as a child-resistant cap.
The outer packaging box is printed with the manufacturer information of Servier Pharmaceuticals LLC.
Drug Appearance
10mg tablets: White to off-white round film-coated tablets, with black "10" printed on one side.
40mg tablets: White to off-white oval film-coated tablets, with black "40" printed on one side.
The tablet surface is smooth, without damage or abnormal spots.
There is no abnormal odor.
Warning Signs of Counterfeit Drugs
The price is significantly lower than the average market price.
The packaging printing is blurry and the colors are incorrect.
The drug is purchased directly from non-medical institutions without a formal prescription.
The seller cannot provide complete cold chain transportation records (if required).
The appearance and odor of the drug do not match the description.
